Price target
319.050.000.00%
The 14 analysts offering 1 year price forecasts for TAK/N have a max estimate of — and a min estimate of —.
Analyst rating
Based on 16 analysts giving stock ratings to TAK/N in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
TAK/N EPS for the last quarter is −4.66 MXN despite the estimation of −0.57 MXN. In the next quarter EPS is expected to reach 3.19 MXN. Track more of TAKEDA PHARMACEUTICAL COMPANY LIMITED financials and stay on top of what is up with the company.
In the next quarter TAKEDA PHARMACEUTICAL COMPANY LIMITED revenue is expected to reach 150.60 B MXN. Check out TAKEDA PHARMACEUTICAL COMPANY LIMITED revenue and earnings and make informed decisions.
According to analysts, TAK/N price target is 319.05 MXN with a max estimate of 367.63 MXN and a min estimate of 285.00 MXN. Check if this forecast comes true in a year, meanwhile watch TAKEDA PHARMACEUTICAL COMPANY LIMITED stock price chart and keep track of the current situation with TAK/N news and stock market news.
We've gathered opinions of 16 analysts rating TAK/N stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.